Menon R K, Cohen R M, Sperling M A, Cutfield W S, Mimouni F, Khoury J C
Division of Endocrinology, University of Cincinnati Medical Center.
N Engl J Med. 1990 Aug 2;323(5):309-15. doi: 10.1056/NEJM199008023230505.
Fetal macrosomia occurs despite nearly normal maternal blood glucose levels in women with diabetes treated with insulin. We examined the hypothesis that it may be caused by insulin transferred as an insulin-antibody complex from the mother to her fetus. We adapted and validated a method based on high-performance liquid chromatography and used it to quantitate insulin in small volumes (0.5 to 1.0 ml) of cord serum from 51 infants born to mothers with insulin-dependent diabetes mellitus.
In mothers receiving only human insulin (n = 6), only human insulin was detected in cord serum. Of the remaining 45 infants, whose mothers received animal insulin during pregnancy, 28 (group 1) had levels of animal (bovine or porcine) insulin (mean [+/- SE], 707 +/- 163 pmol per liter) that constituted 27.4 +/- 2.5 percent of the total insulin concentration (2393 +/- 500 pmol per liter) measured in the cord serum. The cord-serum insulin concentration in the remaining 17 infants (group 2), in whom only human insulin was detected (381 +/- 56 pmol per liter), was only 15 percent of that in group 1 (P less than 0.001). There was a significant correlation between the maternal and the cord-serum concentrations of anti-insulin antibody and the concentration of animal insulin in the baby (r = 0.77, P less than 0.01, and r = 0.76, P less than 0.001, respectively), suggesting that the animal insulin was transferred as an insulin-antibody complex. In group 1 the mean concentration of animal insulin in cord serum was higher in the 12 infants with macrosomia than in the 16 infants without the condition (1113 +/- 321 vs. 402 +/- 110 pmol per liter; P less than 0.05), and the concentration of animal insulin in cord serum correlated with birth weight (r = 0.39, P less than 0.05). The maternal glycosylated hemoglobin values and the incidence of respiratory distress syndrome were similar in groups 1 and 2.
Considerable amounts of antibody-bound insulin are transferred from mother to fetus during pregnancy in some women with insulin-dependent diabetes mellitus; the extent of transfer correlates with the maternal concentration of anti-insulin antibody. The correlation between macrosomia and the concentrations of animal insulin in cord serum indicates that the transferred insulin has biologic activity and suggests that the formation of antibody to insulin in the mother is a determinant of fetal outcome independent of maternal blood glucose levels.
在用胰岛素治疗的糖尿病女性中,尽管孕妇血糖水平接近正常,但仍会出现巨大儿。我们检验了一种假说,即巨大儿可能是由作为胰岛素 - 抗体复合物的胰岛素从母亲转移至胎儿所致。我们改良并验证了一种基于高效液相色谱的方法,并将其用于定量检测51例胰岛素依赖型糖尿病母亲所生婴儿的少量(0.5至1.0毫升)脐血中的胰岛素。
在仅接受人胰岛素治疗的母亲(n = 6)所生婴儿的脐血中,仅检测到人胰岛素。在其余45例婴儿中,其母亲在孕期接受动物胰岛素治疗,其中28例(第1组)的动物(牛或猪)胰岛素水平(均值[±标准误],707±163皮摩尔/升)占脐血中测得的总胰岛素浓度(2393±500皮摩尔/升)的27.4±2.5%。在其余17例仅检测到人胰岛素(381±56皮摩尔/升)的婴儿(第2组)中,脐血胰岛素浓度仅为第1组的15%(P<0.001)。母亲和脐血中抗胰岛素抗体浓度与婴儿体内动物胰岛素浓度之间存在显著相关性(分别为r = 0.77,P<0.01和r = 0.76,P<0.001),表明动物胰岛素是以胰岛素 - 抗体复合物的形式转移的。在第1组中,12例巨大儿的脐血中动物胰岛素平均浓度高于16例非巨大儿(1113±321对402±110皮摩尔/升;P<0.05),且脐血中动物胰岛素浓度与出生体重相关(r = 0.39,P<0.05)。第1组和第2组母亲的糖化血红蛋白值及呼吸窘迫综合征的发生率相似。
在一些胰岛素依赖型糖尿病女性孕期,相当数量的抗体结合型胰岛素从母亲转移至胎儿;转移程度与母亲抗胰岛素抗体浓度相关。巨大儿与脐血中动物胰岛素浓度之间的相关性表明,转移的胰岛素具有生物活性,并提示母亲体内胰岛素抗体的形成是胎儿结局的一个决定因素,独立于母亲血糖水平。